These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7670247)

  • 1. Normal stimulated growth hormone secretion but low peripheral levels of insulin-like growth factor I in prepubertal children with insulin-dependent diabetes mellitus.
    Tapanainen P; Käär ML; Leppäluoto J; Huttunen NP; Knip M
    Acta Paediatr; 1995 Jun; 84(6):646-50. PubMed ID: 7670247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cholinergic modulation on serum insulin-like growth factor-I and its binding proteins in normal and diabetic subjects.
    Ismail IS; Miell JP; Scanlon MF; Peters JR
    Clin Endocrinol (Oxf); 1995 Feb; 42(2):147-52. PubMed ID: 7535669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin treatment normalizes reduced free insulin-like growth factor-I concentrations in diabetic children.
    Bereket A; Lang CH; Blethen SL; Ng LC; Wilson TA
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):321-6. PubMed ID: 8949570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor I, its binding proteins 1 and 3, and growth hormone-binding protein in children and adolescents with insulin-dependent diabetes mellitus: clinical implications.
    Muñoz MT; Barrios V; Pozo J; Argente J
    Pediatr Res; 1996 Jun; 39(6):992-8. PubMed ID: 8725260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is growth hormone hypersecretion in diabetic adolescent girls also a daytime problem?
    Halldin MU; Tylleskär K; Hagenäs L; Tuvemo T; Gustafsson J
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):785-94. PubMed ID: 9713569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the acid-labile subunit of the insulin-like growth factor ternary complex in patients with insulin-dependent diabetes mellitus and severe burns.
    Bereket A; Wilson TA; Blethen SL; Sakurai Y; Herndon DN; Wolfe RR; Lang CH
    Clin Endocrinol (Oxf); 1996 May; 44(5):525-32. PubMed ID: 8762728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinergic control of growth hormone (GH) responses to GH-releasing hormone in insulin dependent diabetics: evidence for attenuated hypothalamic somatostatinergic tone and decreased GH autofeedback.
    Ismail IS; Scanlon MF; Peters JR
    Clin Endocrinol (Oxf); 1993 Feb; 38(2):149-57. PubMed ID: 8094648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone (GH) response to GH-releasing peptide-6 in type 1 diabetic patients with exaggerated GH-releasing hormone-stimulated GH secretion.
    Catalina PF; Mallo F; Andrade MA; García-Mayor RV; Diéguez C
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3663-7. PubMed ID: 9768681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone-binding protein related immunoreactivity is regulated by the degree of insulinopenia in diabetes mellitus.
    Kratzsch J; Keliner K; Zilkens T; Schmidt-Gayk H; Selisko T; Scholz GH
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):673-8. PubMed ID: 8759179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of increased growth hormone secretion on carbohydrate metabolism in adolescents with diabetes.
    Dunger DB; Edge JA; Pal R; Taylor AM; Holly JM; Matthews DR
    Acta Paediatr Scand Suppl; 1991; 377():69-77; discussion 78. PubMed ID: 1723835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of the normal relationships between growth hormone, growth hormone-binding protein and insulin-like growth factor-I in adolescents with insulin-dependent diabetes mellitus.
    Clayton KL; Holly JM; Carlsson LM; Jones J; Cheetham TD; Taylor AM; Dunger DB
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):517-24. PubMed ID: 7955462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth parameters, growth hormone (GH) response to clonidine and circulating insulin-like growth factor-I (IGF-I), free thyroxine (FT4) and cortisol concentrations in relation to glycaemic control in children with insulin-dependent diabetes mellitus.
    Soliman AT; Ahmed HI; Asfour MG
    J Trop Pediatr; 1996 Aug; 42(4):228-32. PubMed ID: 8816035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone-binding proteins, IGF-I and IGF-binding proteins in children and adolescents with type 1 diabetes mellitus.
    Radetti G; Paganini C; Antoniazzi F; Pasquino B; Valentini R; Gentili L; Tato L
    Horm Res; 1997; 47(3):110-5. PubMed ID: 9050949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated administration of growth hormone-releasing hormone with or without previous administration of pyridostigmine in insulin-dependent diabetes mellitus.
    Martina V; Bruno G; Tagliabue M; Maccario M; Bertaina S; Zumpano E; Arvat E; Ghigo E; Camanni F
    Horm Metab Res; 1997 Apr; 29(4):180-3. PubMed ID: 9178028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in the growth hormone-insulin-like growth factor axis in insulin dependent diabetes mellitus.
    Bereket A; Lang CH; Wilson TA
    Horm Metab Res; 1999; 31(2-3):172-81. PubMed ID: 10226799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men.
    Vittone J; Blackman MR; Busby-Whitehead J; Tsiao C; Stewart KJ; Tobin J; Stevens T; Bellantoni MF; Rogers MA; Baumann G; Roth J; Harman SM; Spencer RG
    Metabolism; 1997 Jan; 46(1):89-96. PubMed ID: 9005976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The growth hormone releasing hormone (GHRH) response to a mixed meal is blunted in young adults with insulin-dependent diabetes mellitus whereas the somatostatin response is normal.
    Foot AB; Davidson K; Edge JA; Wass JA; Dunger DB
    Clin Endocrinol (Oxf); 1990 Feb; 32(2):177-83. PubMed ID: 1971774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The growth hormone (GH)-releasing hormone (GHRH)-GH-somatomedin axis: evidence for rapid inhibition of GHRH-elicited GH release by insulin-like growth factors I and II.
    Ceda GP; Davis RG; Rosenfeld RG; Hoffman AR
    Endocrinology; 1987 Apr; 120(4):1658-62. PubMed ID: 3104015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of fasting and pegvisomant on the GH-releasing hormone and GH-releasing peptide-6 stimulated growth hormone secretion.
    Muller AF; Janssen JA; Lamberts SW; Bidlingmaier M; Strasburger CJ; Hofland L; van der Lely AJ
    Clin Endocrinol (Oxf); 2001 Oct; 55(4):461-7. PubMed ID: 11678828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of antagonists of growth hormone-releasing hormone (GHRH) on GH and insulin-like growth factor I levels in transgenic mice overexpressing the human GHRH gene, an animal model of acromegaly.
    Kovacs M; Kineman RD; Schally AV; Zarandi M; Groot K; Frohman LA
    Endocrinology; 1997 Nov; 138(11):4536-42. PubMed ID: 9348175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.